Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
A NEW YOU IS JUST A CLICK AWAY
Quality Verification Third-party testing available (Janoshik)
Closing the GLP-1 Coverage Gap: Q&A with Susan Thomas Mike Hollan , Susan Thomas Key Takeaways Formulary decisions commonly restrict access to T2D and weight loss, creating coverage blind spots as GLP-1 trials mature across broader cardiometabolic and organ-protection indications
Your brain is excellent at pattern recognition
A higher dose of Wegovy (7.2 mg) was approved by the MHRA in January 2026 following the STEP UP trial, which showed: 2 Wegovy 7.2 mg: 20.7% average weight loss Wegovy 2.4 mg: 17.5% average weight loss 50.9% of those on 7.2 mg lost at least 20% of body weight The 7.2 mg dose is not a starting dose
What Current Instructions Say For this glp-1 weight loss page, the 2026 refresh focuses on tirzepatide, safety signals, how, split, zepbound, dose so the article stays close to the question behind "Can You Split a Zepbound Dose
:max_bytes(150000):strip_icc()/VWH-GettyImages-2158519129-372ed708fbbb4c6e9f472a8218cd52ee.jpg)
